Significados de measurable disease en inglés

No significant anti-tumor responses were observed in 27 patients with measurable disease.

All patients had had no previous therapy and had measurable disease.

All patients had received prior anthracycline treatment, and ultimately had progressive bidimensionally measurable disease.

In 27 patients, residual measurable disease was available to determine the response to chemotherapy.

Seventy patients were identified who had measurable disease and had not received prior systemic therapy.

Two of fifteen (13%) patients with measurable disease experienced a partial response to treatment.

All patients had good performance status and measurable disease and only 11 had received prior chemotherapy.

Patients and methods: Fourteen patients with advanced gastric adenocarcinoma with progressive, measurable disease entered the study.

One of the three nonresponders had symptomatic improvement without any response in the measurable disease sites.

Three out of four patients who had measurable disease before the transplant experienced a complete response.

Patients and methods: Eligible women had measurable disease and heavily or minimally pretreated metastatic breast cancer.

Radiographic response was determined using Eastern Cooperative Oncology Group solid tumor response criteria for bidimensional measurable disease.

The 3 Stage II patients, without measurable disease after primary surgery, had an indeterminate response to chemotherapy.

Patients must have measurable disease, adequate hematologic, hepatic, and renal function, and be able to swallow capsules.

Responses were seen in 16 of 19 patients with measurable disease.

Methods: Patients had measurable disease; up to two prior chemotherapeutic regimens were allowed, but must have included a taxane.